Teligent Pharma Erythromycin Gel Recall: Impurities Risk Serious Injury

Take action

Contact the company & request your remedy

Recalling firmTeligent Pharma, Inc.105 Lincoln Avenue, N/A · Buena, NJ 08310

No email on file — write to the address above instead.

✎ GovInfoNow plain-language explainer

What happened, in plain English

Teligent Pharma is recalling Erythromycin Topical Gel USP 2% tubes because they failed impurities tests. This could cause serious injury if used as intended. The product is prescription-only and sold in 30g tubes.

Why it’s dangerous

The gel contains unknown impurities that could cause serious injury when applied to skin. This happens because the product didn't meet safety standards for impurity levels during manufacturing. The risk is highest when the medication is used as directed.

Who’s affected

Prescription patients who have the 30g Erythromycin Topical Gel USP 2% tube with NDC 63739-053-66. People using this medication for skin infections are most at risk.

How to tell if you have this one

Check for the 30g tube labeled 'Erythromycin Topical Gel USP 2%' with NDC 63739-053-66. The product was manufactured in Buena, NJ and distributed by McKesson in Memphis, TN.

Brand
Teligent Pharma
Category
Drug

Based on the official FDA remedy

What to do — step by step

Stop Using Now
Immediately discard the affected gel product as it contains impurities that could cause serious injury.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

No, the product has failed impurities tests and could cause serious injury. Do not use it.

What is the NDC number for this product?

The NDC number is 63739-053-66.

How can I check if I have the recalled product?

Check for the 30g tube labeled 'Erythromycin Topical Gel USP 2%' with NDC 63739-053-66.

Take action

Contact Teligent Pharma

We’ve drafted a message you can send Teligent Pharma to request your refund or repair — edit it as you like.

✉️ Open in email

Subject: Recall D-0716-2022 — Teligent Pharma Teligent Pharma

Hello,

I own a Teligent Pharma that is covered by recall D-0716-2022 from Teligent Pharma.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0716-2022 (February 7, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0716-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.

Teligent Pharma, Inc. recalls Erythromycin Topical Gel USP, 2%, Net Wt 30 g tube, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310,

Stop using this now